The present study demonstrates that augmenting Nrf2-regulated gene expression through the modulation of Keap1 levels provides greater protection against hyperoxia-induced lung hypoalveolarization in neonatal mice, a major clinical manifestation of BPD associated with prematurity in humans. The gene discussed is KEAP1; the disease is bronchopulmonary dysplasia.